Brief: Eiger Biopharmaceuticals Inc - Currently Maintains An Account At Silicon Valley Bank Holding Cash Deposits Of Approximately $8.3 Million
10/03/2023 22:51
March 10 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS INC - CURRENTLY MAINTAINS AN
ACCOUNT AT
SILICON VALLEY BANK HOLDING CASH DEPOSITS OF APPROXIMATELY $8.3
MILLION
Further company coverage: EIGR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview